Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Jennifer S. Temel"'
Autor:
Joseph A. Greer, Vicki A. Jackson, Emily R. Gallagher, Laura A. Petrillo, Areej El-Jawahri, Jennifer S. Temel
Publikováno v:
J Pain Symptom Manage
Context Targeted therapy has revolutionized lung cancer treatment and markedly increased survival, though data are lacking on patient-reported and end-of-life (EOL) outcomes among patients receiving targeted therapy. Objectives This study aimed to co
Autor:
Jennifer S. Temel, Ashley Zhou, Joseph A. Greer, Lara Traeger, Laura A. Petrillo, Robert K. Sommer
Publikováno v:
Journal of Cancer Survivorship. 15:386-391
Molecularly targeted therapies have revolutionized non-small cell lung cancer (NSCLC) treatment. Many patients with metastatic NSCLC receiving targeted therapy may live several years with incurable cancer. We sought to describe how these metastatic c
Autor:
Nwamaka D. Eneanya, Tamar Klaiman, Shananssa G. Percy, Jennifer S. Temel, Elyse R. Park, Allison K. Labbe, Taylor L. Stallings
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Nephrology
BMC Nephrology
Background Older patients with advanced chronic kidney disease often do not understand treatment options for renal replacement therapy, conservative kidney management, and advance care planning. It is unclear whether both clinicians and patients have
Autor:
Patrick Connor Johnson, Eric Roeland, Areej El-Jawahri, Jennifer S. Temel, Emily E. Van Seventer, Christopher P. Bridge, Madeleine Fish, Florian J. Fintelmann, Nora Horick, Katie Kanter, Ryan D. Nipp, Amelie S. Troschel, Ryan B. Corcoran, J. Peter Marquardt, Till D. Best
Publikováno v:
The Oncologist
Background Survival in patients with metastatic colorectal cancer (mCRC) has been associated with tumor mutational status, muscle loss, and weight loss. We sought to explore the combined effects of these variables on overall survival. Materials and M
Autor:
Areej El-Jawahri, Angelo E. Volandes, Jennifer S. Temel, Ashley Zhou, Joseph A. Greer, Laura A. Petrillo, Ryan J. Sullivan
Publikováno v:
Oncologist
Background Immunotherapy is the first-line treatment for melanoma and lung cancer and brings new risks of immune-related adverse events. We aimed to describe patients’ knowledge about risks, benefits, and goals of immunotherapy. Materials and Metho
Autor:
Harry VanDusen, Amir T. Fathi, Gabriela S. Hobbs, Julia Foster, Areej El-Jawahri, Daniel J. DeAngelo, David P. Steensma, Jennifer S. Temel, Thomas W. LeBlanc, Nora Horick, Martha Wadleigh, Lauren Waldman, Richard Stone, Gregory A. Abel, Philip C. Amrein, Joseph A. Greer, Lara Traeger, Netana Markovitz, Andrew M. Brunner
Publikováno v:
Leukemia. 33:2393-2402
Older patients with AML face difficult treatment decisions as they can be treated either with ‘intensive’ chemotherapy requiring prolonged hospitalization, or ‘non-intensive’ chemotherapy. Although clinicians often perceive intensive chemothe
Autor:
Charn Xin Fuh, Jennifer S. Temel, Areej El-Jawahri, James J. MacDonald, Joseph A. Greer, Alina Ward, Steven A. Safren, William F. Pirl, Frank J. Penedo, Alona Muzikansky, Colleen Tallen, Jamie M. Jacobs, Giselle K. Perez, Nicole Pensak, Lara Traeger
Publikováno v:
The Oncologist. 24:1111-1120
Background The aim of this study was to test the efficacy of a tailored cognitive-behavioral therapy (CBT) mobile application (app) to treat anxiety in patients with incurable cancer. Materials and Methods Patients with incurable cancers (n = 145) wh
Autor:
Alyssa L. Fenech, Annemarie D. Jagielo, Olivia Van Benschoten, Lara Traeger, Bailey T. Jones, Jennifer S. Temel, Carlisle E.W. Topping, Nneka N. Ufere, Areej El-Jawahri, Madison A. Clay
Publikováno v:
Transplantation and cellular therapy. 27(4)
Hematopoietic stem cell transplantation (HCT) is an intensive and potentially curative therapy for patients with hematologic malignancies. Patients admitted for HCT experience a prolonged, isolating hospitalization and endure substantial physical and
Autor:
Thomas W. LeBlanc, Yi-Bin Chen, Areej El-Jawahri, Lauren E. Harnedy, Madison A. Clay, Jennifer S. Temel, Stephanie J. Lee, Matthew J. Reynolds, Zachariah DeFilipp, Carlisle E.W. Topping, Regina M. Longley, Julia Rice, Hermioni L. Amonoo, Joseph A. Greer
Publikováno v:
Transplantation and Cellular Therapy. 27:1015.e1-1015.e7
The global coronavirus disease 2019 (COVID-19) pandemic has drastically disrupted cancer care, potentially exacerbating patients' distress levels. Patients undergoing hematopoietic stem cell transplantation (HSCT) may be especially vulnerable to this
Autor:
Areej El-Jawahri, Laura A. Petrillo, Justin F. Gainor, Sienna Durbin, Kerry L. Reynolds, Ryan D. Nipp, Joseph A. Greer, Morgan Rl Lichtenstein, Jennifer S. Temel
Publikováno v:
CancerReferences. 126(10)
BACKGROUND Adults with impaired performance status (PS) often receive immune checkpoint inhibitors (ICIs) for advanced non-small cell lung cancer (NSCLC) despite limited efficacy data and unknown effects on end-of-life care. METHODS This was a retros